Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Sarah De Ferranti, M.D.

Co-Author

This page shows the publications co-authored by Sarah De Ferranti and Jane Newburger.
Connection Strength

4.138
  1. Is Echocardiography Critical in Patients With Kawasaki Disease With a Z-Score < 2 6 Weeks From Onset?-Reply. JAMA Pediatr. 2019 07 01; 173(7):700-701.
    View in: PubMed
    Score: 0.854
  2. Association of Initially Normal Coronary Arteries With Normal Findings on Follow-up Echocardiography in Patients With Kawasaki Disease. JAMA Pediatr. 2018 12 01; 172(12):e183310.
    View in: PubMed
    Score: 0.820
  3. Primary adjunctive corticosteroid therapy is associated with improved outcomes for patients with Kawasaki disease with coronary artery aneurysms at diagnosis. Arch Dis Child. 2021 03; 106(3):247-252.
    View in: PubMed
    Score: 0.232
  4. Anti-thrombosis management of patients with Kawasaki disease: Results from an international survey. Int J Cardiol. 2020 05 15; 307:154-158.
    View in: PubMed
    Score: 0.219
  5. Impact of Socioeconomic Status on Outcomes of Patients with Kawasaki Disease. J Pediatr. 2019 09; 212:87-92.
    View in: PubMed
    Score: 0.213
  6. Risk Model Development and Validation for Prediction of Coronary Artery Aneurysms in Kawasaki Disease in a North American Population. J Am Heart Assoc. 2019 06 04; 8(11):e011319.
    View in: PubMed
    Score: 0.212
  7. Safety and Efficacy of Warfarin Therapy in Kawasaki Disease. J Pediatr. 2017 10; 189:61-65.
    View in: PubMed
    Score: 0.185
  8. Vascular health in Kawasaki disease. J Am Coll Cardiol. 2013 Sep 17; 62(12):1114-1121.
    View in: PubMed
    Score: 0.141
  9. Endothelial pulse amplitude testing: feasibility and reproducibility in adolescents. J Pediatr. 2009 Jun; 154(6):901-5.
    View in: PubMed
    Score: 0.104
  10. Inflammation and changes in metabolic syndrome abnormalities in US adolescents: findings from the 1988-1994 and 1999-2000 National Health and Nutrition Examination Surveys. Clin Chem. 2006 Jul; 52(7):1325-30.
    View in: PubMed
    Score: 0.086
  11. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation. 2004 Oct 19; 110(16):2494-7.
    View in: PubMed
    Score: 0.077
  12. Intraoperative hyperglycemia during infant cardiac surgery is not associated with adverse neurodevelopmental outcomes at 1, 4, and 8 years. Anesthesiology. 2004 Jun; 100(6):1345-52.
    View in: PubMed
    Score: 0.075
  13. Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children. JAMA Cardiol. 2021 Aug 10.
    View in: PubMed
    Score: 0.062
  14. Detailed Assessment of Left Ventricular Function in Multisystem Inflammatory Syndrome in Children, Using Strain Analysis. CJC Open. 2021 Jul; 3(7):880-887.
    View in: PubMed
    Score: 0.060
  15. Socioeconomic and Racial and/or Ethnic Disparities in Multisystem Inflammatory Syndrome. Pediatrics. 2021 05; 147(5).
    View in: PubMed
    Score: 0.060
  16. Multiple Emergency Department Visits for a Diagnosis of Kawasaki Disease: An Examination of Risk Factors and Outcomes. J Pediatr. 2021 05; 232:127-132.e3.
    View in: PubMed
    Score: 0.059
  17. Variation in the management of Kawasaki disease in Australia and New Zealand: A survey of paediatricians. J Paediatr Child Health. 2021 May; 57(5):646-652.
    View in: PubMed
    Score: 0.059
  18. Review of Cardiac Involvement in Multisystem Inflammatory Syndrome in Children. Circulation. 2021 01 05; 143(1):78-88.
    View in: PubMed
    Score: 0.059
  19. Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children. J Clin Invest. 2020 11 02; 130(11):5942-5950.
    View in: PubMed
    Score: 0.059
  20. Atrioventricular Block in Children With Multisystem Inflammatory Syndrome. Pediatrics. 2020 11; 146(5).
    View in: PubMed
    Score: 0.058
  21. Medium-Term Complications Associated With Coronary Artery Aneurysms After Kawasaki Disease: A Study From the International Kawasaki Disease Registry. J Am Heart Assoc. 2020 08 04; 9(15):e016440.
    View in: PubMed
    Score: 0.057
  22. Low-Molecular-Weight Heparin vs Warfarin for Thromboprophylaxis in Children With Coronary Artery Aneurysms After Kawasaki Disease: A Pragmatic Registry Trial. Can J Cardiol. 2020 10; 36(10):1598-1607.
    View in: PubMed
    Score: 0.057
  23. Missed or delayed diagnosis of Kawasaki disease during the 2019 novel coronavirus disease (COVID-19) pandemic. J Pediatr. 2020 Jul; 222:261-262.
    View in: PubMed
    Score: 0.057
  24. Variation in the management of Kawasaki disease. Arch Dis Child. 2020 10; 105(10):1004-1006.
    View in: PubMed
    Score: 0.053
  25. Treatment Intensification in Patients With Kawasaki Disease and Coronary Aneurysm at Diagnosis. Pediatrics. 2019 06; 143(6).
    View in: PubMed
    Score: 0.053
  26. Kawasaki disease and immunisation: A systematic review. Vaccine. 2017 03 27; 35(14):1770-1779.
    View in: PubMed
    Score: 0.045
  27. Kawasaki disease and immunisation: Standardised case definition & guidelines for data collection, analysis. Vaccine. 2016 12 12; 34(51):6582-6596.
    View in: PubMed
    Score: 0.044
  28. Coronary Artery Aneurysm Measurement and Z Score Variability in Kawasaki Disease. J Am Soc Echocardiogr. 2016 Feb; 29(2):150-7.
    View in: PubMed
    Score: 0.041
  29. Temporal trends in pulse pressure and mean arterial pressure during the rise of pediatric obesity in US children. J Am Heart Assoc. 2014 May 08; 3(3):e000725.
    View in: PubMed
    Score: 0.037
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.